Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over […]
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over […]
– Total Revenues of $539.5 million, Cabozantinib Franchise U.S. Net Product Revenues of $478.1 million – – GAAP Diluted EPS
CARLSBAD, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),
CNN — Delta Air Lines on Friday sued cybersecurity firm CrowdStrike in a Georgia state court after a global outage in July caused
SCRANTON, Pa., Oct. 25, 2024 /PRNewswire/ — On October 25, 2024, the board of directors of Peoples Financial Services Corp.
“We can confirm that an UNRWA vehicle has been hit in Deir Al-Balah,” a spokesperson confirmed. “So far, we have
Pharming Group N.V. Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023,
argenx SE October 24, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to
Bread Financial Holdings (NYSE: BFH) released its September 2024 performance metrics. The company reported end-of-period
Vancouver, British Columbia–(Newsfile Corp. – October 24, 2024) – good natured Products Inc. (TSXV: GDNP.H) (OTC Pink: GDNPF) (the “Company”